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Edited by Pe´ter FriedrichAbstract Meprins are unique plasma membrane and secreted
metalloproteinases that are highly regulated at the transcrip-
tional and post-translational levels. Meprin a and b subunits
are abundantly expressed in kidney and intestinal epithelial cells,
are secreted into the urinary tract and intestinal lumen, and are
found in leukocytes and cancer cells under certain conditions.
Their location and proteolytic activities indicate functions at
the interface of the host and the external environment, and in
traﬃcking of macrophages and metastases of cancer cells. These
proteases can be detrimental when there is tissue damage or dis-
ruption, as in acute renal injury or intestinal inﬂammation, and
there is evidence they are involved in movement of leukocytes
and cancer cells to sites of infection or in metastasis, respec-
tively.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Meprins are highly expressed at the brush border mem-
brane of proximal tubule cells of the kidney and epithelial
cells of the intestine, particularly in the ileum and colon,
and in mesenteric leukocytes [1,2]. For example, meprin pro-
teins were estimated to compose approximately 5% of the
brush border membrane protein in rodent kidneys, second
only to actin in abundance [3]. These proteases are multido-
main, highly glycosylated proteins that act extracellularly,
and are either bound to the plasma membrane by transmem-
brane segments, or are secreted or shed into extracellular
spaces [4,5]. Meprin proteases are composed of two evolu-
tionarily related subunits, a and b, that are approximately
50% identical at the amino acid level. The subunits are en-
coded on two genes: the a gene is on human chromosomeAbbreviations: DSS, dextran sulfate sodium; IBD, inﬂammatory bowel
disease; UTI, urinary tract infection; RT-PCR, reverse transcriptase-
polymerase chain reaction; GAPDH, glyceraldehyde phosphate dehy-
drogenase
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unit on chromosome 18 in both the mouse and human gen-
omes [6]. The subunits can be expressed separately, or
coordinately, and consequently they form homo or hetero-
complexes where the basic unit is a disulﬁde-linked dimer.
Both subunits are synthesized as membrane spanning pro-
teins with small cytoplasmic tails, and the bulk of the pro-
tein is extracellular. However, the meprin a subunit is
proteolytically cleaved during biosynthesis so that it loses
its transmembrane domain. Thus, meprin a exists at the
membrane only when it associates with meprin b, which ex-
ists as a type I protein at the plasma membrane. Membrane
forms of meprins are dimeric (homodimeric b; meprin B) or
tetrameric (hetero a2b2 or a3b2 complexes) (see Fig. 1A).
The secreted form of meprin a tends to oligomerize into
high molecular mass complexes containing 10–100 subunits
(dimers that associate noncovalently), forming the largest
proteases known to exist (see Fig. 1B). The self-associating
homo-oligomeric complexes of meprin A are secreted as la-
tent proteases (containing the prosequence) and can move
through extracelluar spaces in a non-destructive manner,
and deliver a concentrated form of this metalloproteinase
to sites that have activating proteases, such as site of inﬂam-
mation, infection or cancerous growth [4,7]. Thus, meprin
structures provide means to concentrate proteolytic activity
at the cell membrane (through homo–hetero-oligomeric
complexes) and extracellularly (through homotypic
interactions).
Meprins are capable of cleaving a wide range of substrates,
from bioactive peptides, such as gastrin and angiotensin, to
extracellular matrix proteins, such as collagen IV, ﬁbronectin
and nidogen [8,9]. The heterooligomeric form of meprin was
identiﬁed as a major matrix degrading protease in studies of
rat kidney [10,11]. The peptide bond speciﬁcities of meprins
a and b diﬀer substantially, indicating diﬀerent functions, how-
ever, they can both hydrolyze extracellular matrix proteins.
Among the best substrates for meprin b are gastrin and osteo-
pontin, which are growth factors and chemokines [8]. Meprin
a, but not b, cleaves cytokines such as monocyte chemoattrac-
tant protein-1, and this could be important in immune
responses [12].
Meprin metalloproteases are highly regulated at the tran-
scriptional and post-translational level and are normally re-
stricted to speciﬁc locations, but they can be detrimental
to host tissues when there is tissue damage and disruption
of cells, e.g., in intestinal inﬂammation and kidney
disruption.blished by Elsevier B.V. All rights reserved.
Fig. 2. Immunoﬂuorescent localization of the meprin b metallopro-
tease on the brush border membrane of the mouse ileum and in
macrophages in the lamina propria during inﬂammation induced by
dextran sulfate sodium. Meprin b, green; macrophage-speciﬁc protein
F4/80, red; colocalization of the latter two proteins appears yellow.
Nuclei, blue.
Fig. 1. (A) Domain and oligomeric structure of meprins a and b. Domains are S, signal sequence; Pro, prosequence; Protease, catalytic domain;
MAM, meprin, A5 protein, protein tyrosine phosphatase l; MATH, meprin and TRAF homology; AM, after MATH; I, inserted domain; EGF,
epidermal growth factor-like, TM, transmembrane-spanning; C, cytoplasmic domain. The MATH and AM domains are now designated the TRAF
domain (4,5). (B) Electron micrograph of various forms of secreted, latent homooligomeric meprin A demonstrating high molecular mass complexes.
Row 1, closed rings and crescents (containing about 10 to 12 meprin a subunits); rows 2 and 3 show tubes and spirals containing up to 100 subunits.
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In situ hybridization studies of embryonic and adult mice
and immunohistochemistry demonstrated the tissue-speciﬁc
expression of meprin subunits in the epithelial cells of kidney
and intestine only [13]. These studies also demonstrated that
there was diﬀerential regulation of meprins a and b after birth.
Meprin a was present in the fetus by day 11, increased expres-
sion after birth, and expression was precipitously decreased in
the intestine after weaning (21 days). By contrast, meprin b in-
creased during fetal growth and after birth, and became the
predominant isoform of the enzyme in the intestine after wean-
ing. The kidney expression of mouse meprin subunits were
strain-dependent; all strains express both subunits during fetal
stages, some strains increase both subunits after birth (e.g.,
C57BL/6) while others only express meprin b, and down regu-
late meprin a (e.g., C3H/He). The consequence of the expres-
sion patterns in mice is that meprin b is the predominant
form of meprin in the adult intestine; while meprin a is abun-
dantly expressed in kidney of most adult mice, it is not ex-
pressed in certain inbred strains of mice (mainly strains of
the H-2k haplotype, e.g., CBA, C3H, AKR). Low meprin a
expression in the kidney is inherited as an autosomal recessive
trait [14].
It has been known for some time that meprin b is highly ex-
pressed on the brush border membrane of the ileum (see Fig.
2). Meprin a and b are also expressed in leukocytes of the
mouse mesenteric lymph node [2]. When mice were given dex-
tran sulfate sodium (DSS) in their drinking water, to generate
an experimental model for inﬂammatory bowel disease (IBD),
only meprin b was present in lymph nodes of DSS-treated mice
[2]. In addition, leukocytes from meprin b null mice are deﬁ-
cient in their ability to invade into matrigel. Other functional
properties of the meprin b/ leukocytes, such as phagocyto-
sis and superoxide release were not diﬀerent in the / and
+/+ genotypes. The presence of meprin b in the draining lymph
node of the intestine, coupled with the decreased ability of me-
prin b-macrophages to migrate through matrigel implicatesthis protease in leukocyte transmigration important to the im-
mune response, and to IBD which is aggravated by leukocyte
inﬁltration.
To test whether meprins are induced by the microbial ﬂora
of the intestine, RNA samples were obtained (from Dr. Jeﬀrey
Gordons laboratory at Washington University) from mice
that were either germ-free, colonized with Bacteriodes thetai-
otaomicron at day 10, or conventionalized at 10 days. The mice
were on two diﬀerent strain backgrounds, NMRI and C57BL/
6. Reverse transcriptase-polymerase chain reaction (RT-PCR)
analyses showed no diﬀerence between the expression of me-
prin a or b for any of these mice. Thus, the microbial ﬂora
are not responsible for induction of intestinal meprins, but
rather meprins are innately present in the mouse gut.
Fig. 3. Western blot of meprin a in human urine from healthy women
and women with acute urinary tract infections. Concentrated urine
samples (40 ll each) were immunoblotted with a human recombinant
meprin a antibody. Low or no meprin immunoreactivity was observed
in samples from healthy subjects (sample I.D. 31, 32, 33, and 34) while
high meprin immunoreactivity was observed in samples from subjects
suﬀering from acute UTI (sample I.D. 52, 53, 56, and 57).
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High levels of meprin a at the brush border membrane in ro-
dent kidneys have been implicated in tissue damage caused by
insults such as ischemia, while low levels of meprin a and b
have been associated with ﬁbrosis [15,11,16]. Acute renal fail-
ure is a common disorder that aﬀects about 5% of all hospital-
ized patients, and has a mortality rate of over 50%. An
understanding of the cellular and molecular mechanisms of
kidney injury is critical to learning how to improve mortality.
Studies of inbred strains of mice subjected to ischemia reperfu-
sion have revealed that mice that express low levels of
kidney meprin a as adults (C3H/He, CBA) have markedly less
kidney damage compared to those that express high levels of
kidney meprin a (ICR, C57BL/6) [15]. Studies with rats have
demonstrated that high levels of active meprin A can be cyto-
toxic [11]. The latter authors found active meprin A was cyto-
toxic to renal cells in culture (LLC-PK1 and MDCK cells) and
that actinonin, a potent inhibitor of meprin a, could protect
against meprin damage in vitro and in vivo in a model ische-
mia-reperfusion injury. They also demonstrated that after
acute ischemic renal tubule damage there is a shift in meprin
location form the brush border membrane to cytoplasmic com-
partments and to the tubular lumen. One interpretation of
these observations is that once tissue is damaged, high levels
of active meprins are found in places other than the apical
membrane (cytoplasm, basolateral side of the cell, and cell–cell
junctions) and are damaging. Inhibitors of meprins can protect
against this type of damage.
Multiple studies have demonstrated that meprin expression
is downregulated in models of renal injury that lead to acute
renal failure. For example, renal pathology associated with
hydronephrosis (unilateral urethral obstruction) occurs with
an early and progressive decline in rat meprin a and b subunit
mRNA and protein [17]. Microarray analysis demonstrated
marked declines in mouse meprin b expression in acute renal
ischemic reperfusion injury and in adriamycin-induced
nephropathy [18,16]. The latter authors also reported that me-
prin b is downregulated during transdiﬀerentiation of renal tu-
bule epithelial cells to a ﬁbroblast-like phenotype in vitro on
exposure to TGF-ß and EGF, suggesting a role in ﬁbrogenesis.
Meprin b expression is also downregulated in collagen IVA3
knockout mice that develop Alports syndrome and renal
pathology [19]. It appears that meprins are downregulated in
a variety of situations that lead to cell death through apoptosis
or necrosis, and are upregulated in speciﬁc highly diﬀerentiated
cells and in some proliferating cells (such as cancer cells and
leukocytes under certain conditions). The location, balance
and regulation of meprins are important in kidney disease
progression.
Urinary tract infections are one of the most common bacte-
rial infections for mankind, and around 50% of women are af-
fected at one point in their lifetime. Recurrent urinary tract
infections are also one of the problems after kidney transplan-
tation, and this appears to be related to ischemic conditions
and time taken between removal of the kidney and transplan-
tation. There are multiple factors involved in recurrent infec-
tions, however, there is a need to understand the
mechanisms involved to develop more eﬀective therapies, in-
crease the incidence of renal allograft survival, and prevent re-
nal scarring associated with infection. The secreted form of
meprin a is in an ideal location for preventing or lesseninginfections of the urinary tract. Experimental models of urinary
tract infections have established that there are mouse strain
diﬀerences in susceptibility to bacterial infection, and that they
are related to the major histocompatibility complex, the area
of the genome that encodes meprin a. There is clear evidence
that C3H/He mice are more susceptible to infections by uro-
pathic bacteria than Balb/c mice [20]. C3H/He mice express
low meprin a in adult kidney, while Balb/c mice express high
levels. Moreover, susceptibility is recessive, as is low meprin
a expression. Our hypothesis is that meprin a is one of the
factors that determine the susceptibility to urinary tract
diseases. Meprin a is poised to be activated in the urinary tract;
it is secreted from the proximal tubule of the kidney into the
lumen as an inactive complex with high proteolytic potential,
and can be readily activated by trypsin-like proteases (e.g.,
subtilisin). Meprin a and b knockout mice will be valuable
tools to determine whether in fact meprins are important fac-
tors for susceptibility to urinary tract infections by uropathic
bacteria.
Little is known about meprin in human urinary tract infec-
tions (UTIs). To examine meprin expression in human urine,
voided urine samples from premenopausal women with a his-
tory of frequent UTIs, without a history of frequent UTIs, and
with an acute UTI were collected for analysis. The urine sam-
ples were concentrated 10-fold, and their total protein and cre-
atinine concentrations were determined. Quantitative Western
blotting showed that meprin a protein is detectable in the urine
of premenopausal women at low concentrations, and that con-
centrations are variable from subject to subject. No correlation
between the urinary levels of meprin protein and the suscepti-
bility of women to UTIs was observed. Eighty-nine percent of
healthy women had low or undetectable levels of urinary me-
prin, similar to certain inbred strains of mice (e.g., C3H/He
mice). In contrast, the majority (86%) of women suﬀering from
an acute UTIs had high (greater than 5.2 ng) or very high
(greater than 9.1 ng) levels of meprin protein in the urine
(Fig. 3). These results are in concordance with studies of me-
prin expression in the intestine, where meprin subunit expres-
sion is markedly increased during inﬂammation as a result of
leukocyte inﬁltration.4. Meprins in intestinal disease
Meprin expression in the intestinal tract is highest in the
ileum and large intestine where host and microorganisms are
in contact, and where intestinal inﬂammatory diseases develop.
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cally heterogeneous intestinal diseases that result in damage
to intestinal epithelium and aﬀect 1 million people in the
USA [21]. The two major forms of IBD, ulcerative colitis
and Crohns disease, involve chronic inﬂammation of the colon
or the ileum plus colon, respectively, and are thought to be
caused by genetic and environmental factors that aﬀect
host-microbe interactions and production of inﬂammatory
mediators. Candidate genes for susceptibility to IBD have been
identiﬁed, and these include the NOD2 gene on chromosome
16 (for Crohns), and susceptibility loci on chromosome
19p13 and the HLA region on chromosome 6 for both ulcera-
tive colitis and Crohns disease [22]. Experimental models of
IBD and clinical studies point to a dysregulation of the intes-
tinal immune response, but no suitable therapy has proven
eﬀective for most. For example, treatments of patients aimed
at decreasing activity of TNFa or a4b7 integrins, that decrease
leukocyte traﬃcking to the intestine, have had beneﬁcial ef-
fects, however, there are side eﬀects and a signiﬁcant percent-
age do not respond. There is consensus, however, that
blockage of macrophage inﬁltration into the intestine is a good
therapeutic strategy for IBD.
Our results and those of others have led to the hypothesis
that meprins play a role in the pathogenesis of IBDs. Data
indicate that meprins inﬂuence IBD by aﬀecting intestinal
leukocyte dissemination to inﬂammatory sites in the gut,
by interacting with bacteria at the epithelial surface, by deg-
radation of compounds such as defensins that kill bacteria,
or by exacerbating host tissue damage in the inﬂamed gut.
Previous studies had demonstrated high expression of me-
prin subunits in leukocytes of the lamina propria of human
inﬂammatory sites [23]. This observation, plus the known
ability of meprins to hydrolyze extracellular matrix proteins,
led to the speculation that meprins play a role in the move-
ment of macrophages to inﬂammatory sites. Our studies
with meprin b knockout mice, and macrophages from the
lymph nodes of mice with an experimentally induced form
of IBD, have strengthened our proposal that meprin b plays
an important role in intestinal leukocyte dissemination to
the gut [2]. These observations need to be extended to show
that macrophages of meprin b/ mice do in fact move less
eﬃciently to sites of inﬂammation in vivo, and once there do
less damage. The implication of meprin b in the disease pro-
cess warrants investigation of administration of inhibitors of
the protease in vivo to determine whether pathology is
lessened.
The contribution of the bacterial ﬂora in the gut to IBD is
unclear. However, it is known that germ-free mice do not de-
velop IBD, thus bacteria likely have a determinative role in the
process. In the course of studying the meprin b knockout mice
we discovered that the aerobic intestinal bacterial ﬂora of the
null mice were distinct from the wild-type (unpublished obser-
vations). Thus, there is a diﬀerence in the bacterial proﬁle for
the genotypes. This diﬀerence was worsened upon administra-
tion of DSS, an intestinal irritant. In general, the adverse ef-
fects of the insult correlated with the load of aerobic gram-
negative bacteria. The fact that the bacterial proﬁle is altered
in mice deﬁcient in meprin b provides a clue that the eﬀects
of meprins in the progression of IBD involve interactions of
meprin proteases with bacteria or their products, or in the
modulation of host molecules, such as defensins that kill
bacteria.5. Meprin upregulation in cancer cells
Cultured human cancer cell lines from a variety of tissues ex-
press a unique isoform of meprin b [24–26]. In cancer cells, the
human MEP1B gene is expressed from a transcription start
site about 70 bp upstream from the normal site used in the
kidney [26]. Use of the upstream start site results in a slightly
longer 5 0 untranslated region of the mRNA, but no changes to
the protein coding regions. Meprin b mRNA expression is in-
creased in cancer cells by tumor promoters, consistent with the
presence of multiple AP-1 and PEA3 elements (Fos/Jun and
Ets binding sites) in the MEP1B promoter, whereas these
elements are rarely found in the MEP1A promoter [27]. Both
meprin a and b are expressed in mesenteric lymph nodes,
where meprin b aﬀects the migration of intestinal leukocytes
[2]. It has also been shown that meprin a is secreted from both
the apical and basolateral surfaces of the human colon cancer
cell line Caco-2, supplying proteolytic activity to the stromal
compartment [23]. Active meprin a was also detected in a
majority of colorectal tumor samples. Meprins potential role
in cell migration and extracellular matrix remodeling is further
supported by in vitro observations that meprin a cleaves extra-
cellular matrix components, such laminin-1 and 5, gelatin, and
ﬁbronectin [28,9,8].
To examine the proposition that meprins are involved in the
progression of tumor cells from a non-invasive /non-metastatic
phenotype to a more aggressive phenotype, meprin expression
was studied in cells with diﬀering metastatic potential. One
pair of cells examined was human colon cancer cells SW480
and SW620. SW480 cells were established from a primary co-
lon tumor, while the SW620 cells were isolated from a lymph
node metastasis of colon tumor cells in the same individual a
year later [29]. The SW480/SW620 cell system has been vali-
dated as a model for colon cancer progression [30]. SW620
cells are more locally invasive and form more liver metastases
from intrasplenic injection sites. In addition, SW620 cells pro-
duce more of the secreted matrix metalloprotease MMP-7 [31].
In addition, the endogenous expression of meprin subunits in
the human hepatoma cell lines, HepG2 and Huh7, was inves-
tigated since colon cancer cells frequently metastasize to the li-
ver. Using the constitutive glyceraldehyde phosphate
dehydrogenase (GAPDH) mRNA as a template loading con-
trol, the amount of meprin a and b mRNA in SW480,
SW620, Huh7, and HepG2 cells were compared by end-point
RT-PCR (Fig. 4). The metastatic SW620 cells express 3-fold
more meprin a mRNA than the nonmetastatic SW480 cells,
while meprin b levels in SW480 and SW620 are similar. These
results indicate that the increase in metastatic potential of
SW620 cells correlates with the levels of meprin a expression.
The amount of meprin a mRNA in HepG2 cells were at least
100-fold more than in SW620, while meprin b mRNA levels in
HepG2 cells were less than either SW480 or SW620. Direct
comparison of HepG2 and Huh7 for expression of meprin a
indicated that these hepatocarcinoma cell lines diﬀered in their
level of meprin a expression. HepG2 cells expressed signiﬁ-
cantly more meprin a mRNA than Huh7 cells.
In addition to RNA, the presence of secreted meprin a pro-
tein in media collected from HepG2 and Huh7 cell cultures
was examined by Western blot analysis and activity assays.
Data from mouse and human systems indicate that overex-
pression of meprin a relative to meprin b aﬀects the extracellu-
lar localization of the meprin a subunit. The covalent
Fig. 4. End-point RT-PCR analysis of meprin expression in human
cultured liver cancer cells (HepG2 and Huh7), and in human cultured
colon cancer cells SW480 (480) and SW620 (620). When normalized to
the GAPDH loading controls, meprin a expression is higher in the
metastatic SW620 cells compared to the SW480 primary tumor cells.
Likewise meprin a mRNA levels are higher in HepG2 cells compared
to the Huh7 liver cancer cells. GAPDH, glyceraldehyde phosphate
dehydrogenase.
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of meprin a at the apical surface of kidney and intestinal brush
border epithelial cells [32]. However, in tissues with low meprin
b levels, or in meprin b knock-out mice, the meprin a subunit is
released from the cell surface, indicating that meprin a does
not bind to other cell surface proteins [33,34]. Based on the dif-
ferential expression of meprin a and b mRNA determined by
RT-PCR, it is predicted that the overexpression of meprin a
mRNA relative to meprin b mRNA in HepG2 cells would re-
sult in the release of meprin a protein into the culture media.
When conditioned media from HepG2 and Huh7 cells was
tested for the presence of meprin a protein by Western blot,
only HepG2 cells produced detectable meprin a. The lower le-
vel of meprin a mRNA in Huh7 cells in comparison the
HepG2 implies that Huh7 cells produce less meprin a protein
and it is retained at the cell surface in a/b complexes. The lack
of detectable meprin a in Huh7 conditioned media supports
this hypothesis.
Meprin a is secreted in a latent form from Caco-2 colon can-
cer cells and activated by the serine protease plasmin, which
can be provided by stromal ﬁbroblasts [7]. Plasmin activation
of human meprin is speciﬁc for meprin a and does not occur
with meprin b [35]. Proteolytic activity assays indicate that
the meprin a protein secreted by HepG2 cells is in the latent
form. Conditioned HepG2 media alone had no meprin a pro-
teolytic activity in a standard bradykinin assay [8]. Proteolytic
activity was detected, however, upon pretreatment of the med-
ia with trypsin, a serine protease that removes the propeptide
of human meprin a, indicating that the HepG2 secreted meprin
a protein was latent. As in the colon cancer system, the activa-tion of secreted meprin a in hepatocarcinomas requires serine
proteases provided by the stromal compartment.
Release of meprin a from the cell surface to the extracellular
mileu has implications for cancer cell invasion and metastasis.
The high level of meprin a in HepG2 cell line presents a model
for further studies on the role of secreted meprin a in cancer
cells.6. Conclusions
Meprins are highly regulated metalloproteinases, as indi-
cated by both tissue-speciﬁc expression patterns and diﬀeren-
tial expression patterns observed during birth and weaning.
The data indicate an important function for meprins in several
disease states, including acute renal failure, cancer, IBD, and
UTI. Numerous studies have demonstrated that the location
and downregulation of meprins in the kidney play a key role
in the severity and progression of renal injury, with meprins
exacerbating the diseased condition. Upregulation of meprins
in cancer cells along with the ability of meprins to cleave extra-
cellular matrix proteins implicates a role in the growth, inva-
sion, and metastasis of cancer cells. Meprins may also have a
role in inﬂammation, since meprin subunit expression is in-
creased in both an in vivo model of IBD as a result of leuko-
cyte inﬁltration and also in the urine from women with acute
UTI. The diverse expression pattern of meprins among a vari-
ety of disease conditions warrants further investigation of this
unique protease. A more thorough understanding of how mep-
rins are regulated will provide insight into progression of and
ultimately better therapies for these conditions.References
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